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ABSTRACT
Introduction: Multidrug-resistant tuberculosis (MDR-TB) isan emerging public health problem in many regions
of the world, particularly in developing nations. Accurate and rapid diagnosis is essential in the management of
MDR-TB, not only to optimize treatment but also to prevent transmission. Aims: To evaluate drug resistance in
culture isolates by conventional and molecular methods and detect drug resistance gene in MDR-TB patients.
Material  and Method: 100  newly  diagnosed pulmonary tuberculosis  (TB) diagnosed  patients  attending  TB
Clinic,  Gandhi Hospital, Secunderabad  were included  in the study.  Two  sputum  samples  collected  from  the
patients  were  subjected to  sputum microscopy, culture,  Drug  Susceptibility  Testing  (DST). Geno Type
Mycobacterium Tuberculosis Drug Resistance (MTBDR) plus assay was done on the culture isolates to detect
Rifampicin and Isoniazid (INH) resistance. Results: Out of 100 samples, 48 % smear positivity by Ziehl Neelsen
(ZN) method, 51 % culture positivity on LJ medium,11.7% multi drug resistance for Rifampicin and Isoniazid
with conventional drug susceptibility – Proportion method,17.6 % drug resistance by molecular  method – Geno
Type MTBDR plus was observed. Among the 4 Rifampicin (Rif) resistant isolates 2isolates showed mutation
(mut) at D516V and in other 2 isolates only wild type (WT) was missing but no mut was seen . In the 1 Isoniazid
(INH) resistant isolate WT was missing, but no mutation was seen. Among the 4 Rif +INH resistance all showed
mut at S531L for RIF and at S315T1. Conclusion: The Genotype MTBDR assay is a rapid and reliable tool for
the routine direct detection of MTB strains and of strains resistant to INH and RIF in smear positive, highly
infectious patients. The rapid turn around time of the test enables the optimization of the therapy of these patients
before confirmatory culture results are available. The test does not require viable organisms and thus reduces the
biohazard risk in the laboratory.
Keywords: Mycobacterium Tuberculosis, Drug Resistance, Genotype MTBDR assay.
INTRODUCTION
Tuberculosis  is  the  leading  cause  of  mortality  in
adults due to an infectious agent and accounts for 26
% of all preventable adult deaths globally.
1At present
global incidence of this disease is increasing at the
rate of 0.4% per year. It is currently regarded as the
seventh most important cause of premature mortality
and is going to be one of the first ten leading causes
of disease burden even in the year 2020.
2 In India, out
of  one  billion  population,  each    year  about  two
million  develop active  tuberculosis  and  up to  half
million die . Its   prevalence and incidence in India is
30.4% and 1.2% respectively.
3
Multidrug-resistant  tuberculosis  (MDR-TB)  is an
emerging public health problem in many regions of
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the world, particularly in developing nations. Multi-
drug  resistant  tuberculosis strains  are  generally
considered  to  be those  resistant  to  at  least  two
drugs,such  as INH and Rifampicin.  From  a
microbiological perspective, the resistance is caused
by a genetic mutation that makes a drug ineffective
against the mutant bacilli. MDR-TB is a man-made
phenomenon – poor treatment, poor drugs and poor
adherence lead to the development of MDR-TB.
4The
frequency  of  multi  drug  resistance  varies
geographically  and  acquired  resistance  is  more
common than primary resistance.
Accurate  and rapid  diagnosis is  essential  in  the
management of  MDR-TB,  not  only to optimize
treatment but also to prevent transmission. Mutations
confined to a short 81 bp DNA region in the rpoB
gene, encodingthe ß-subunit of the RNA polymerase,
have  been  found in      95%  of Rifampicin-resistant
strains. Mutations  in  this region  are  an excellent
marker  for  MDR-TB.
4 The  successful  treatment  of
tuberculosis  depends  on  timely  diagnosis  and
selection  of  an  adequate  treatment  strategy. Use of
molecular techniques decreases the time necessary for
the detection of drug resistancefrom several weeks to
a  few  days  or  even less,  and  a  patient’s  treatment
regimen can be adjusted more rapidly to account for
any detected drug resistance .
5
MATERIALS AND METHODS
Sample  size: Two  early  morning sputum  samples
from  100  cases  of  clinically  suspected newly
diagnosed adult pulmonary tuberculosis attending TB
clinic, Gandhi  Hospital,  Secunderabad    for  over  a
period  of  one  year  were  included  in  the  study. 20
cases  of  clinically  non  tuberculous  etiology  were
included  as  controls. The  study  was  approved  by
Institutional  Ethics  committee  of  Gandhi  Medical
College, Secunderabad
Inclusion criteria: (more than any two of the below
to be fulfilled) Fever and cough with expectoration
for more than 3 weeks not responding to  antibiotics,
Gradual  weight  loss, Loss  of  appetite, Abnormal
findings in chest radiograph
Exclusion  criteria: Cases  already  on anti
tuberculosis treatment (ATT) or had been confirmed
as having Tuberculosis were excluded.
Collection  of  sample: Two  early  morning  sputum
samples  were  collected  in  a  sterile  leak  proof
container.
All  the  samples  were  subjected  to decontamination
and concentration by Modified Petroff’s  method
6
Smears  were made  from  the  purulent  portion  of
sputum and  stained by  Ziehl Neelsen  method for
Microscopy and grading was done as follows (Table
1)
Table 1: Grading of sputum smears
No.  Of  AFB
seen
Result grading Fields
examined
10 AFB/OIF Positive 3+ 20
1-10AFB/OIF Positive 2+ 50
10-99AFB/OIF Positive 1+ 100
1-9AFB/OIF Scanty Record  exact
number
200
NO.  OF  AFB
in 100 OIF
negative ----- 100
Note: AFB – Acid fast bacilli, OIF – oil immersion
field
All  the  samples  were inoculated onto Lowenstein
Jensen  (LJ) media  and  incubated  at  37°C  for  a
maximum  of  8  weeks. In  case  of  any  growth  of
Mycobacteria, date of first appearance of colony was
noted and was further incubated for further growth.
All the culture positive strains were identified by Para
Nitro Benzoic Acid tests and Nitrate reductase test.
6
Drug  Susceptibility  testing  was  done  by  the
molecular method - GenoType®MTBDR plus assay
and compared with conventional –Proportion method.
Proportion  Method
6:  The  proportion  method
calculates the proportion of resistant bacilli present in
the medium with the drug. Two appropriate dilution
of the bacilli, 10¯
2 and10¯
4dilutions (undiluted = 106
to 108 CFU/ml), were inoculated on drug-containing
and  drug-free  media,  in  order  to obtain  countable
colonies  on  both  media. The  ratio  of  number  of
colonies observed on the drug -containing media to
drug-free  medium  indicates  proportion  of  resistant
bacilli  present  in  the  strain. Drug  Concentration  of
Rifampicin added to LJ Media was 40 μg/ml and INH
added to LJ media was 0.2 μg/ml .
Incubation  and Reading: Inoculated  slopes  were
incubated at 37°C. Growth is read at 28 days.
Growth is recorded Confluent = 3+; More than 100
colonies = 2+; Record actual number of colonies = 1-
100 cols.
6
Interpretation of the test
1. First  reading  is  taken  at  28th  day  after
inoculation.
2. Colonies only on the slopes are counted.377
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3. The  average  number  of  colonies  obtained from
the drug-containing slopes indicate the number of
resistant bacilli contained in the inoculum.
4. Dividing  the  number of  colonies  in  drug
containing slopes by that in drug free slopes gives
the proportion of resistant bacilli existing in the
strain.  Below  a  certain  value – the  critical
proportion – the strain is classified as sensitive;
above that value, it is classified as resistant. The
proportions are reported as percentages.
5. If, according to the criteria indicated below, the
result  of  the  reading  made  on  the  28th  day  is
“resistant”, no further reading of the test for that
drug  is  required:  the  strain  is  classified  as
resistant.  If  the  result  at  the  28th  day  is
“sensitive”, a second reading is made on the 42nd
day only for the sensitive strain.
6. If growth on the control media is poor even after
six weeks (i.e., few or no colonies on the 10-4
bacterial dilution), the test should be repeated.
GenoType® MTBDR plus (Hain Lifescience,)
Methodology
The  Geno Type  MTBDR plus test  is  based  on the
DNA STRIP technology and permits the molecular
genetic  identification  of  the  Mycobacterium
tuberculosis complex and its resistance to Rifampicin
and/or  Isoniazid from  cultivated  samples  or
pulmonary  smear-positive  clinical  specimens.    The
identification of Rifampicin resistance is enabled by
the detection of the most significant mutations of the
rpoB  gene  (coding  for  the  β-sub-unit  of  the RNA
polymerase).  For  detection  of  high  level Isoniazid
resistance,  the  katG  gene  (coding  for  the  catalase
peroxidase)  is  examined  and  for  detection  of  low
level Isoniazid resistance, the promoter region of the
INHA  gene (coding  for  the  NADH  enoyl  ACP
reductase) is examined.
Procedure:
It is divided into three steps-
1. DNA extraction
2. A  multiplex  amplification  with  biotinylated
primers
3. Reverse hybridization.
Procedure  was done and  results were interpreted
according to  the  protocol  provided  by the
manufacturer.
7
RESULTS
Age wise distribution of cases shown in Table 2. The
majority of the patients were found to be in the range
of 30-39 yrs (34%). Out of 100 patients included in
the study, 71 were males and 29 females. Comparison
of results of microscopy versus culture on LJ media
(Table 3). In this study 44 (48 %) were smear positive
by Ziehl  Neelsen (ZN  method), 55 (51  %) were
culture positive on LJ  medium. All  the  isolated
strains  belonged  to Mycobacterium  Tuberculosis
(MTB) complex. The minimum time taken for growth
on LJ media by any strain was 17 days and maximum
period  taken  was  39  days. Maximum  number  of
strains  (34) showed  visible  growth  between  22- 28
days. Mean duration of incubation for isolation was
25.66 days.
6 (11.76%) isolates  showed  drug  resistance by
convention  method (proportion  method).  Out  of  6
drug resistant isolates, 3 isolates showed resistance to
only Rif and  3 isolates  showed  resistance  to  both
drugs.
Out  of  51  isolates, 6  isolates  (11.7%) were  multi
drug  resistant for Rifampicin  and Isoniazid with
conventional drug susceptibility – Proportion method,
and 9 isolates  (17.6%)were  drug  resistant by
molecular  method – Geno Type MTBDR plus . The
ratio of resistance to both drugs by the two methods is
3:4
Among 4 Rif resistant isolates - 2 showed mut at
D516V  and  in  remaining 2  isolates only  WT was
missing, but  no  mut  seen.1 INH resistant  isolate
showed WT missing but no mut was seen Among 4
Rif +INH resistant  isolates - All    showed  mut  at
S531L for Rif, and at S315T1 for INH
Table 2: Age wise distribution of cases
Distribution  of
age in yrs
No. of cases percentage
0-9 01 1%
10-19 10 10%
20-29 19 19%
30-39 34 34%
40-49 13 13%
50-59 12 12%
60 and above 11 11%
total 100 100%378
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Table  3:  Comparison  of results  of  microscopy  versus
culture on LJ media
Smear +ve Smear -ve total
Culture +ve 42 13 55
Culture -ve 02 43 45
total 44 56 100
Table  4:  Comparison  of  drug  resistance  by
conventional dst and genotype mtbdr plus method
TEST Rifampicin
Only
Rifampicin
+ INH
INH
only
Tota
l
DST 3 3 - 6
Geno Type 4 4 1 9
Table 5: ANALYSIS OF RIF AND INH RESISTANCE
Sample no 16 28 46 52 62 64 73 83 98
rpoB  WT
Missing
3,4 8 8 3,4 - 8 8 7 7
rpo B mut MUT
1
MUT 3 MUT3 MUT
1
- MUT3 MUT3 NO
MUT
NO
MUT
Codon
analysed
513 -
519
530-533 530-533 513 -
519
- 530-533 530-533 - -
Mutation D516V S531L S531L D516V - S531L S531L - -
katG  WT
Missing
- Missing Missing - Missing Missing Missing - -
kat G mut - - MUT1 - - MUT1 MUT1 - -
Codon
analysed
- - 315 - - 315 315 - -
Mutation - - S315T1 - - S315T1 S315T1 - -
inh A WT - - - - - - - - -
inh A MUT - - - - - - - - -
Codon
analysed
- - - - - - - - -
Mutation - - - - - - - - -
RESISTANCE Rif Rif+INH Rif+INH Rif INH Rif+INH Rif+INH Rif Rif
Note: WT-wild type; MUT-Mutation; KatG-gene; Rif- Rifampicin; INH- Isoniazid
DISCUSSION
Drug resistance is a threat to TB control programs. It
is a major public health problem because treatment is
prolonged and complicated, cure rates are well below
those  for drug- susceptible  TB,  and  patients  may
remain  infectious  for  months  or  years, despite
receiving the best available therapy. Rapid detection
of drug resistance would help not only to optimize
treatment of MDR-TB, but also breaking the chains
of transmission and  identification of  any  hot  spot
regions for proper implementation of the TB control
programs.
The youngest patient included in this study was 21
years  old  while  the  oldest  was 80  years  old.
Maximum number  of  patients  suffering  from
tuberculosis  were  in  the  age  group  of  30-39  years
(34%)  followed  by  20-29  years  (19%).  Thus  more
than half (53%) of patients were in the age group of
20-39 years. Robert etal
7 reported 62% of cases.
In this study out of 100 cases, 71 were males and 29
females. The male to female ratio was 2.4:1 which is
in  accordance  with  the  study  conducted  by
V.K.Dhingra
8 who reported 2.2:1.
The  smear positivity  in  this  study  was  42%  by
standard ZN staining. S Rishi etal
9 reported 54.3%
smear  positivity  while  Negi  SS  etal
10 reported
33.79% smear positivity.
The present study showed 51% culture positivity on
LJ media, which correlated with a study conducted by
Rishi et al
9 who reported 50.6%. The mean duration
of incubation time for Mycobacteria on LJ media was
25.6days  while  Rishi  s etal
9 and  Negi  S et  al
10
reported  28.8  and  24  days  as  mean  duration  of
isolation respectively.
This study showed cavities in 48% of patients which
is in comparison with Dhingra et al
8 who reported
44% on chest X ray.379
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In this  study it  was  found  that  3  isolates (5.88 %)
were resistant  to Rifampicin alone and  3  isolates
(5.88 %) were resistant to both Rifampicin and INH
by Proportion method. None of the isolates showed
resistance to INH alone. This  study correlated with
W.C Yam et al
11 who reported 39 to be  multi drug
resistant  among  352  isolates 18  isolates  (5.11  %)
were resistant to only Rif and 21 isolates  (5.96 %)
resistant  to  both the  drugs. Meera  Sharma  et  al
12
conducted  study  on 200  isolates and  14 isolates
(7.0%) were resistant to only Rif and 15 isolates (7.5
%) resistant to both the drugs, and 1 isolate (0.5 %)
showed  resistant  to  only INH. Naga  Suresh  et  al
13studied 56 isolates Out of which 5 isolates (8.9 %)
were resistant to only Rif and 3 isolates (5.35 %)
were resistant to both the drugs.
In this study the 51 isolates were subjected to Geno
Type MTBDR plus. 4 isolates (7.8 %) were resistant
to Rifampicin, 4  isolates  (7.8  %) were  resistant  to
both Rifampicin and INH and 1 isolate (1.96 %) was
resistant to INH alone. 4 isolates showed absence of
rpoB    WT8,  codon  531  with    rpoB    MUT3    i.e
mutation at  S531L  with absent  katG  WT ,  codon
315 showing  katG MUT 1 mutation at S315T1 . 2
isolates showed absence of rpoB  WT 3 ,4  with  rpoB
MUT 1 i.e mutation at 513 -519 codon mutation at
D516V 2 isolates showed absence of rpoB WT7 with
no mutation.1 isolate showed absence of only katG
WT with no mutation .
This study correlated with Bahram Nasr et al
14who
reported 3 isolates (7.2 % ) resistant to Rifampicin
and  6.8  % to  both  the  drugs  ,  with  absence  of
rpoBWT8    with    rpoB    MUT3    i.e    mutation  at
S531L  and  absent  katG  WT   showing  katG  MUT
1 mutation at S315T1  and  absence of rpoB  WT 3 ,4
with  rpoB MUT 1, mutation at 513 -519 codon i.e
mutation at D516V  was seen. Doris Hillemann et al
15reported 9.2 % of strains   resistant to Rifampicin
and  8.1  % isolates showed  resistance  to both  the
drugs. Mutations were seen in 531 codon for rpoB
315 for katG, 13.6 % and in 526, 516 codon.5 isolates
showed  absence  of  wild  types  with  no  mutation.
Paolo Miotto  et  al
16 reported in 3.8  % of isolates
showed  D516V substitution  in  rpoB  and  4.4  %  in
S531L region.
In this study with Proportion method drug resistance
was  seen in  6 isolates and  with rapid  molecular
method  Geno Type  MTBDR  plus 9  isolates were
drug  resistant.  As  compared  to  the  conventional
method  which  showed  3  isolates  to  be  resistant  to
both the drugs, the Geno Type MTBDR plus assay
showed 4 isolates to be resistant to both the drugs.  3
isolates  were  resistant  only  to Rifampicin by
conventional method and 4 isolates showed resistance
only to Rifampicin by the GenoType MTBDR plus
assay, the ratio being 3:4. Our study correlated with
Doris Hillemann et al
15who reported 3.2: 4 ratio in
comparison of both methods. Guessan Kouassi et al
17
showed 1: 6 ratios. Girts Skenders et al 18 reported
1:7  ratio  of  both methods. In addition,  one isolate
showed  resistance  to INH alone  by  GenoType
MTBDR  plus  method  which  was  not  shown  by
Proportion method.
CONCLUSION
The results of the present study have shown that the
MTBDR plus assay is easy to perform and has the
capability for the rapid detection of Rifampicin - and
INH-resistant M.  tuberculosis. MTBDR plus  assay
has  been  proven  to  be  suitable  for  application  for
culture isolates .MTBDR assay can identify the most
frequent mutations involved in resistance to RIF and
INH and  can  reveal  the  presence  of  additional
mutations by negative hybridization results with the
wild-type probes. MTBDR assay identified 100% of
the phenotypically  resistant  strains  for Rifampicin
and Isoniazid resistance.
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